lunes, 5 de marzo de 2018

New on NCI Websites, March 2018 - National Cancer Institute

New on NCI Websites, March 2018 - National Cancer Institute

National Cancer Institute

New on NCI Websites, March 2018

March 2, 2018, by NCI Staff
NCI’s collection of cancer information products is constantly growing, so periodically we provide updates on new and updated content of interest to the cancer community.

Fiscal Year 2017 Budget Fact Book Published

NCI's budget for the fiscal year (FY) that ended on September 30, 2017, was $5.69 billion. Learn how NCI distributed those funds among its various research programs and funding mechanisms in the newly published NCI Budget Fact Book. New this year, the Budget Fact Book web pages feature interactive graphical tools that allow visitors to focus on the data they want to see. It also includes a breakdown of how NCI distributed the first $300 million allocated for the Cancer Moonshot™.

Cancer Trends Progress ReportUpdated

The Cancer Trends Progress Report summarizes the nation's advances against cancer in relation to Healthy People targets established by the Department of Health and Human Services. The report—intended for policy makers, researchers, and public health professionals—includes key measures of progress along the cancer control continuum and uses national trend data to illustrate where improvements have been made.

Infographic Highlights Cancers Linked to Overweight and Obesity

Being overweight or obese is a common risk factor for several types of cancer. A new infographic illustrates the cancers that are known to be associated with overweight and obesity.

BRCA Mutations and Cancer Risk Extensively Revised

Women who inherit harmful changes in the BRCA1 or BRCA2 genes have a much higher risk of breast and ovarian cancer than women in the general population. This updated fact sheet explains the role of genetic testing for women with a personal or family history that suggests they may have a BRCA mutation, what the results of these tests might mean, and how the information from these tests can help women make health decisions.

iCURE Program Launched

NCI's new Intramural Continuing Umbrella of Research Experiences (iCURE) supports mentored research experiences at the NCI campuses in Bethesda, Rockville, and Frederick, Maryland, for qualified students and scientists. iCURE is an extension of the NCI Continuing Umbrella of Research Experiences (CURE) program, the goal of which is to support the careers of its participants around the country as they progress toward research independence and to foster and sustain diversity in the biomedical field. The CURE and iCURE programs support promising candidates from middle school through junior investigator levels. NCI's Center to Reduce Cancer Health Disparities manages both programs.

New Web Page Highlights CCR Landmarks in Cancer Research and Treatment

Basic and clinical investigators at NCI's Center for Cancer Research (CCR) have made many important scientific discoveries over the years. A new web page, Landmarks: Decades of Breakthroughs in Cancer Research and Treatment, provides a detailed look at many of the center’s most important accomplishments.

CCR Website Tells Patients' Stories

At the NIH Clinical Center, many of NCI's clinical researchers work directly with patients to find new and better ways to treat cancer. The CCR website now features patient stories that illustrate this important collaboration between doctors and patients. They include stories of a couple finding relief in the aftermath of Hurricane Maria, a man walking with purpose after an HPV-related head and neck cancer diagnosis, a woman who is fearless in the face of small cell lung cancer, and a physician who is facing her own ovarian cancer.

Answering Commonly Asked Questions about Dense Breasts

Women with dense breast tissue have a higher risk of breast cancer. This new page answers commonly asked question about dense breasts, how to know if you have dense breasts, things to consider regarding screening, and ongoing research.

New Resource Highlights NCI's Role in Advancing Immunotherapy Research

Advances in cancer immunotherapy are the result of long-term investments in basic research on the immune system—research that continues today. This new resource explains NCI's ongoing role in the research that makes these advances in cancer immunology possible.

New DCEG Linkage Newsletter Published

"Conversation with a Former Fellow" Series Launched

DCEG has kicked off a series of Q&A conversations with former fellows in the division about their career paths and advice for current and future fellows. The first conversation in the series was with former fellow Elizabeth Yanik, Ph.D., who is now an assistant professor at the Washington University School of Medicine in St. Louis.

< Older Post

Lung Cancer Screening Most Beneficial for Those at Highest Risk, Analysis Suggests

No hay comentarios:

Publicar un comentario